Recursion Pharmaceuticals, Inc. (RXRX) NASDAQ

5.50

+0.18(+3.38%)

Updated at April 17 04:00PM

Currency In USD

Valuation

Market Cap1.85B
Enterprise Value1.37B
P/E Ratio-3.99
PEG Ratio0.47
Price/Sales Ratio36.95
Price/Book Ratio1.79
Enterprise/Revenue28.69
Enterprise/EBITDA-3.94

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-7.88
Operating Margin-8.15

Management Effectiveness

Return On Assets-0.32
Return On Equity-0.73

Income Statement

Revenue58.84M
Revenue/Share0.17
Gross Profit13.6M
EBITDA-426.72M
Net Income-463.66M
Diluted EPS-1.69

Balance Sheet

Total Cash594.35M
Total Cash/Share1.77
Total Debt108.49M
Total Debt/Equity0.1
Current Ratio3.81
Book Value Per Share3.08

Price History

52-Week Change-25.17
52-Week High12.36
52-Week Low3.79
Moving Average 50 Days6.73
Moving Average 200 Days6.92

Statistics

Average Volume25.71M
Shares Outstanding395.07M
% Held by Institutions107.84

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A